• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.040 +0.030 (+1.49%)
Delayed Quote Updated: 3:58 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,961
Open 2.000
Bid (Size) 1.960 (2,000)
Ask (Size) 2.200 (3,000)
Prev. Close 2.010
Today's Range 1.960 - 2.140
52wk Range 1.800 - 3.065
Shares Outstanding 5,567,490
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aytu BioPharma Inc. (NASDAQ:AYTU) Shares Jump 125% on Q4 Beat and Strong EXXUA Launch ↗
September 22, 2026
Via Chartmill
News headline image
Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
September 22, 2026
Fourth quarter fiscal 2026 net revenue increased 6.4% to $16.1 million from $15.1 million in the prior-year quarter Fourth quarter fiscal 2026 Adjusted EBITDA of $0.5 million EXXUA net revenue of $6.6... 
From Aytu BioPharma, Inc.
Via ACCESS Newswire

Performance

52-Week Range 33.4% below 52-week high
2.040
1.8052W Low 3.0652W High
1 Week 4.7% below 1-week high
1.941W Low 2.141W High

Aytu BioPharma, Inc. - Common Stock (AYTU) traded between $1.80 and $3.06 over the past 52 weeks and last traded at $2.04, 33.4% below its 52-week high. Over the past week it ranged between $1.94 and $2.14.

Past 12 Months
+3.6%
+3.6%
-5.1%
-21.5%
-26.4%
-12.1%
1W +$0.07
1M +$0.07
3M -$0.11
6M -$0.56
YTD -$0.73
1Y -$0.28

AYTU was -12.1% over the past year, -21.5% over six months, -26.4% year to date, +3.6% in the last week.

12 Months vs Market
AYTU
-12.1%
DIA
+13.0%
SPY
+15.5%
QQQ
+18.3%
IWM
+10.4%

Over the past 12 months AYTU returned -12.1% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 0.86× 3-mo avg
Today 29,961 3-mo avg 34.7K
1W
27.5K
1M
48.0K
3M
34.7K
6M
35.7K
YTD
48.6K
1Y
55.1K

AYTU most recently traded 29,961 shares against a 3-month average daily volume of 34.7K.

More News

Read More
News headline image
Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026
September 16, 2026
From Aytu BioPharma, Inc.
Via ACCESS Newswire
News headline image
Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
June 01, 2026
Via ACCESS Newswire
Aytu BioPharma (NASDAQ:AYTU) Surges 23% as EXXUA Launch Gains Early Traction in Mixed Q3 Results ↗
May 13, 2026
Via Chartmill
Aytu BioPharma Inc (NASDAQ:AYTU) Posts Q2 Revenue Beat Amid EXXUA Launch Costs ↗
February 03, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Via Benzinga
News headline image
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
May 18, 2026
Via ACCESS Newswire
News headline image
Aytu (AYTU) Q3 2026 Earnings Transcript ↗
May 13, 2026
Via The Motley Fool
News headline image
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
May 13, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
May 06, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma AYTU Q2 2026 Earnings Transcript ↗
February 03, 2026
Via The Motley Fool
News headline image
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
February 03, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
January 20, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
January 20, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
January 13, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City
January 12, 2026
Via ACCESS Newswire
News headline image
Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City
December 18, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
December 15, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
November 24, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma Inc (NASDAQ:AYTU) Reports Q1 2026 Revenue Beat and Progress on EXXUA Launch ↗
November 13, 2025
Via Chartmill
News headline image
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
November 13, 2025
Via ACCESS Newswire
News headline image
Insights into Aytu BioPharma's Upcoming Earnings ↗
November 12, 2025
Via Benzinga
News headline image
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
November 05, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
October 28, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Aytu BioPharma, Inc. - Common Stock publicly traded?
Yes, Aytu BioPharma, Inc. - Common Stock is publicly traded.
What exchange does Aytu BioPharma, Inc. - Common Stock trade on?
Aytu BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aytu BioPharma, Inc. - Common Stock?
The ticker symbol for Aytu BioPharma, Inc. - Common Stock is AYTU on the Nasdaq Stock Market
What is the current price of Aytu BioPharma, Inc. - Common Stock?
The current price of Aytu BioPharma, Inc. - Common Stock is 2.040
When was Aytu BioPharma, Inc. - Common Stock last traded?
The last trade of Aytu BioPharma, Inc. - Common Stock was at 10/16/26 03:58 PM ET
What is the market capitalization of Aytu BioPharma, Inc. - Common Stock?
The market capitalization of Aytu BioPharma, Inc. - Common Stock is 11.36M
How many shares of Aytu BioPharma, Inc. - Common Stock are outstanding?
Aytu BioPharma, Inc. - Common Stock has 11M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap